Authors: Karle, P Renner, M Salmons, B Gunzburg, WH

Citation: P. Karle et al., Necrotic, rather than apoptotic, cell death caused by cytochrome P450-activated ifosfamide, CANC GENE T, 8(3), 2001, pp. 220-230

Authors: Lohr, M Hoffmeyer, A Kroger, JC Freund, M Hain, J Holle, A Karle, P Knofel, WT Liebe, S Muller, P Nizze, H Renner, M Saller, RM Wagner, T Hauenstein, K Gunzburg, WH Salmons, B

Citation: M. Lohr et al., Microencapsulated cell-mediated treatment of inoperable pancreatic carcinoma, LANCET, 357(9268), 2001, pp. 1591-1592

Authors: Kammertoens, T Gelbmann, W Karle, P Alton, K Saller, R Salmons, B Gunzburg, WH Uckert, W

Citation: T. Kammertoens et al., Combined chemotherapy of murine mammary tumors by local activation of the prodrugs ifosfamide and 5-fluorocytosine, CANC GENE T, 7(4), 2000, pp. 629-636

Authors: Lohr, M Bago, ZT Bergmeister, H Ceijna, M Freund, R Gelbmann, W Gunzburg, WH Jesnowski, R Hain, J Hauenstein, K Henninger, W Hoffmeyer, A Karle, P Kroger, JC Kundt, G Liebe, S Losert, U Muller, P Probst, A Puschel, K Renner, M Renz, R Saller, R Salmons, B Schuh, M Schwendenwein, I von Rombs, K Wagner, T Walter, I

Citation: M. Lohr et al., Cell therapy using microencapsulated 293 cells transfected with a gene construct expressing CYP2B1, an ifosfamide converting enzyme, instilled intra-arterially in patients with advanced-stage pancreatic carcinoma: a phase I/II study, J MOL MED-J, 77(4), 1999, pp. 393-398

Authors: Gunzburg, WH Karle, P Muller, P Saller, RM Liebe, S Lohr, JM Salmons, B

Citation: Wh. Gunzburg et al., New strategies for treatment of pancreatic cancer: cell therapy and gene therapy, EUROCANCER 98, 1998, pp. 303-304